Logo image of CRWV

COREWEAVE INC-CL A (CRWV) Stock Fundamental Analysis

NASDAQ:CRWV - Nasdaq - US21873S1087 - Common Stock - Currency: USD

148.97  -0.73 (-0.49%)

Premarket: 145.8 -3.17 (-2.13%)

Fundamental Rating

2

Overall CRWV gets a fundamental rating of 2 out of 10. We evaluated CRWV against 82 industry peers in the IT Services industry. CRWV may be in some trouble as it scores bad on both profitability and health. CRWV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CRWV had negative earnings in the past year.
CRWV Yearly Net Income VS EBIT VS OCF VS FCFCRWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

CRWV's Return On Assets of -4.29% is on the low side compared to the rest of the industry. CRWV is outperformed by 68.29% of its industry peers.
The Return On Equity of CRWV (-30.55%) is worse than 68.29% of its industry peers.
CRWV has a Return On Invested Capital (1.74%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.29%
ROE -30.55%
ROIC 1.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRWV Yearly ROA, ROE, ROICCRWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 200 300 400

1.3 Margins

CRWV has a Operating Margin of 16.93%. This is amongst the best in the industry. CRWV outperforms 89.02% of its industry peers.
CRWV has a better Gross Margin (74.24%) than 91.46% of its industry peers.
Industry RankSector Rank
OM 16.93%
PM (TTM) N/A
GM 74.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRWV Yearly Profit, Operating, Gross MarginsCRWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRWV is destroying value.
The number of shares outstanding for CRWV remains at a similar level compared to 1 year ago.
CRWV has a worse debt/assets ratio than last year.
CRWV Yearly Shares OutstandingCRWV Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M
CRWV Yearly Total Debt VS Total AssetsCRWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.08 indicates that CRWV is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.08, CRWV is doing worse than 60.98% of the companies in the same industry.
CRWV has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.61, CRWV is doing worse than 76.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 2.08
ROIC/WACC0.19
WACC9.24%
CRWV Yearly LT Debt VS Equity VS FCFCRWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2B -2B 4B -4B

2.3 Liquidity

CRWV has a Current Ratio of 0.44. This is a bad value and indicates that CRWV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.44, CRWV is doing worse than 93.90% of the companies in the same industry.
CRWV has a Quick Ratio of 0.44. This is a bad value and indicates that CRWV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.44, CRWV is doing worse than 93.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
CRWV Yearly Current Assets VS Current LiabilitesCRWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The earnings per share for CRWV have decreased strongly by -57.81% in the last year.
Looking at the last year, CRWV shows a very strong growth in Revenue. The Revenue has grown by 736.64%.
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, CRWV will show a very strong growth in Revenue. The Revenue will grow by 101.40% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year144.33%
Revenue Next 2Y139.41%
Revenue Next 3Y101.4%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
CRWV Yearly Revenue VS EstimatesCRWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 5B 10B 15B

0

4. Valuation

4.1 Price/Earnings Ratio

CRWV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRWV Price Earnings VS Forward Price EarningsCRWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRWV is valued a bit more expensive than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 66.52
CRWV Per share dataCRWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CRWV!.
Industry RankSector Rank
Dividend Yield N/A

COREWEAVE INC-CL A

NASDAQ:CRWV (6/12/2025, 8:00:01 PM)

Premarket: 145.8 -3.17 (-2.13%)

148.97

-0.73 (-0.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change75.61%
Market Cap71.50B
Analysts72
Price Target70.09 (-52.95%)
Short Float %6.11%
Short Ratio1.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)46.72%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 37.33
P/FCF N/A
P/OCF N/A
P/B 23.3
P/tB 23.48
EV/EBITDA 66.52
EPS(TTM)-2.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.99
BVpS6.39
TBVpS6.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.29%
ROE -30.55%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.9%
ROICexgc 1.91%
OM 16.93%
PM (TTM) N/A
GM 74.24%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 4.17
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z 2.08
F-ScoreN/A
WACC9.24%
ROIC/WACC0.19
Cap/Depr(3y)1492.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)732.41%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year144.33%
Revenue Next 2Y139.41%
Revenue Next 3Y101.4%
Revenue Next 5YN/A
EBIT growth 1Y2344.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year935.58%
EBIT Next 3Y236.97%
EBIT Next 5YN/A
FCF growth 1Y-436.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.01%
OCF growth 3YN/A
OCF growth 5YN/A